Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- City: Georgia
- Country: United States Of America
- Bursa Uludag University Affiliated: No